Correlation Between Tff Pharmaceuticals and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Tff Pharmaceuticals and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tff Pharmaceuticals and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tff Pharmaceuticals and Elevation Oncology, you can compare the effects of market volatilities on Tff Pharmaceuticals and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tff Pharmaceuticals with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tff Pharmaceuticals and Elevation Oncology.
Diversification Opportunities for Tff Pharmaceuticals and Elevation Oncology
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tff and Elevation is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Tff Pharmaceuticals and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Tff Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tff Pharmaceuticals are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Tff Pharmaceuticals i.e., Tff Pharmaceuticals and Elevation Oncology go up and down completely randomly.
Pair Corralation between Tff Pharmaceuticals and Elevation Oncology
Given the investment horizon of 90 days Tff Pharmaceuticals is expected to under-perform the Elevation Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Tff Pharmaceuticals is 1.38 times less risky than Elevation Oncology. The stock trades about -0.07 of its potential returns per unit of risk. The Elevation Oncology is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 90.00 in Elevation Oncology on September 2, 2024 and sell it today you would lose (26.00) from holding Elevation Oncology or give up 28.89% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Tff Pharmaceuticals vs. Elevation Oncology
Performance |
Timeline |
Tff Pharmaceuticals |
Elevation Oncology |
Tff Pharmaceuticals and Elevation Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tff Pharmaceuticals and Elevation Oncology
The main advantage of trading using opposite Tff Pharmaceuticals and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tff Pharmaceuticals position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.Tff Pharmaceuticals vs. Gain Therapeutics | Tff Pharmaceuticals vs. In8bio Inc | Tff Pharmaceuticals vs. Lantern Pharma | Tff Pharmaceuticals vs. INmune Bio |
Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Transaction History View history of all your transactions and understand their impact on performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |